Proteomic analyses of genes regulated by heterogeneous nuclear ribonucleoproteins A/B in Jurkat cells

Proteomics

Volumn 14, Issue 11, 2014, Pages 1357-1366

  Yeh, Yuan Ming ^a   Chen, Chi Yuan ^b   Huang, Pei Rong ^a   Hsu, Chia Wei ^a   Wu, Chih Ching ^a,c   Wang, Tzu Chien V ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cell proliferation; HnRNP A1, A2 B1, A3; Jurkat cells; Quantitative proteomics

Indexed keywords

CRK LIKE PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B; PROTEOME; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; SMALL INTERFERING RNA;

ARTICLE; BIOLOGICAL FUNCTIONS; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; HUMAN; HUMAN CELL; JURKAT CELL LINE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE STUDY; RNA INTERFERENCE; TRANSCRIPTION REGULATION; CYTOLOGY; DEVICES; EQUIPMENT DESIGN; GENE EXPRESSION REGULATION; GENETICS; MASS SPECTROMETRY; METABOLISM; PROCEDURES;

CELL PROLIFERATION; EQUIPMENT DESIGN; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; JURKAT CELLS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84901841454     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300549     Document Type: Article

References (30)

1. Dreyfuss, G., Matunis, M. J., Pinol-Roma, S., Burd, C. G., hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 1993, 62, 289-321.
2. Pinol-Roma, S., Choi, Y. D., Matunis, M. J., Dreyfuss, G., Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev. 1988, 2, 215-227.
3. He, Y., Smith, R., Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell. Mol. Life Sci. 2009, 66, 1239-1256.
4. Celis, J. E., Bravo, R., Arenstorf, H. P., LeStourgeon, W. M., Identification of proliferation-sensitive human proteins amongst components of the 40 S hnRNP particles. Identity of hnRNP core proteins in the HeLa protein catalogue. FEBS Lett. 1986, 194, 101-109.
5. LeStourgeon, W. M., Beyer, A. L., Christensen, M. E., Walker, B. W. et al., The packaging proteins of core hnRNP particles and the maintenance of proliferative cell states. Cold Spring Harb. Symp. Quant. Biol. 1978, 42(Pt 2), 885-898.
6. He, Y., Brown, M. A., Rothnagel, J. A., Saunders, N. A., Smith, R., Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J. Cell Sci. 2005, 118, 3173-3183.
7. Patry, C., Bouchard, L., Labrecque, P., Gendron, D. et al., Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res. 2003, 63, 7679-7688.
8. Huang, P. R., Tsai, S. T., Hsieh, K. H., Wang, T. C., Heterogeneous nuclear ribonucleoprotein A3 binds single-stranded telomeric DNA and inhibits telomerase extension in vitro. Biochim. Biophys. Acta 2008, 1783, 193-202.
9. Sheng, W. Y., Wang, T. C., Proteomic analysis of the differential protein expression reveals nuclear GAPDH in activated T lymphocytes. PloS One 2009, 4, e6322.
10. Yu, C. C., Lo, S. C., Wang, T. C., Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Biochem. J. 2001, 355, 459-464.
11. Yu, C. J., Chang, K. P., Chang, Y. J., Hsu, C. W. et al., Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J. Proteome Res. 2011, 10, 3778-3788.
12. Huang, P. R., Yeh, Y. M., Pao, C. C., Chen, C. Y., Wang, T. C., N-(1-Pyrenyl) maleimide inhibits telomerase activity in a cell free system and induces apoptosis in Jurkat cells. Mol. Biol. Rep. 2012, 39, 8899-8905.
13. Lin, H. R., Wu, C. C., Wu, Y. H., Hsu, C. W. et al., Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B(1)-mediated cytotoxicity. J. Proteome Res. 2013, 12, 3434-3448.
14. Liu, H. P., Wu, C. C., Kao, H. Y., Huang, Y. C. et al., Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration. Mol. Cell. Proteomics 2011, 10, M900641-MCP900200.
15. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B. et al., Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 2005, 4, 2010-2021.
16. Bantscheff, M., Boesche, M., Eberhard, D., Matthieson, T. et al., Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer. Mol. Cell. Proteomics 2008, 7, 1702-1713.
17. Griffin, T. J., Xie, H., Bandhakavi, S., Popko, J. et al., iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer. J. Proteome Res. 2007, 6, 4200-4209.
18. Khan, A. P., Poisson, L. M., Bhat, V. B., Fermin, D. et al., Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Mol. Cell. Proteomics 2010, 9, 298-312.
19. Mueller, L. N., Brusniak, M. Y., Mani, D. R., Aebersold, R., An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 2008, 7, 51-61.
20. Peng, P. H., Wu, C. C., Liu, S. C., Chang, K. P. et al., Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J. Proteomics 2011, 74, 744-757.
21. Wang, L. J., Hsu, C. W., Chen, C. C., Liang, Y. et al., Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes. Mol. Cell. Proteomics 2012, 11, 1230-1244.
22. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J. et al., Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 2010, 9, 1100-1117.
23. Birge, R. B., Kalodimos, C., Inagaki, F., Tanaka, S., Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun. Signal. 2009, 7, 13.
24. Uemura, N., Griffin, J. D., The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J. Biol. Chem. 1999, 274, 37525-37532.
25. Nobes, C. D., Hall, A., Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81, 53-62.
26. Tsai, N. P., Wei, L. N., RhoA/ROCK1 signaling regulates stress granule formation and apoptosis. Cell. Signal. 2010, 22, 668-675.
27. Basile, J. R., Gavard, J., Gutkind, J. S., Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J. Biol. Chem. 2007, 282, 34888-34895.
28. Zhang, S., Tang, Q., Xu, F., Xue, Y. et al., RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors. Mol. Cancer Res. 2009, 7, 570-580.
29. Nishihara, H., Maeda, M., Oda, A., Tsuda, M. et al., DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines. Blood 2002, 100, 3968-3974.
30. Tsai, N. P., Wei, L. N., RhoA/ROCK1 signaling regulates stress granule formation and apoptosis. Cell Signal. 2009, 22, 668-675.